Geode Capital Management
RCEL icon

Geode Capital Management’s Avita Medical RCEL Stock Holding History

Geode Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Sell
339,822
-203,152
-37% -$876K ﹤0.01% 3271
2026
Q1 		$2.01M Buy
542,974
+63,789
+13% +$268K ﹤0.01% 3119
2025
Q4 		$1.65M Buy
479,185
+147,722
+45% +$589K ﹤0.01% 3231
2025
Q3 		$1.69M Sell
331,463
-286,879
-46% -$1.5M ﹤0.01% 3234
2025
Q2 		$3.27M Sell
618,342
-1,365
-0.2% -$9.93K ﹤0.01% 2946
2025
Q1 		$5.05M Buy
619,707
+22,112
+4% +$207K ﹤0.01% 2647
2024
Q4 		$7.65M Buy
597,595
+3,159
+0.5% +$37.3K ﹤0.01% 2526
2024
Q3 		$6.37M Buy
594,436
+8,361
+1% +$78.5K ﹤0.01% 2632
2024
Q2 		$4.64M Buy
586,075
+43,059
+8% +$410K ﹤0.01% 2769
2024
Q1 		$8.71M Buy
543,016
+14,359
+3% +$232K ﹤0.01% 2402
2023
Q4 		$7.25M Buy
528,657
+30,039
+6% +$344K ﹤0.01% 2505
2023
Q3 		$7.29M Buy
498,618
+23,461
+5% +$397K ﹤0.01% 2446
2023
Q2 		$8.08M Buy
475,157
+225,098
+90% +$3.3M ﹤0.01% 2417
2023
Q1 		$3.49M Sell
250,059
-2,697
-1% -$28.7K ﹤0.01% 2792
2022
Q4 		$1.67M Buy
252,756
+798
+0.3% +$4.78K ﹤0.01% 3125
2022
Q3 		$1.33M Buy
251,958
+1,651
+0.7% +$10.2K ﹤0.01% 3253
2022
Q2 		$1.19M Sell
250,307
-194,399
-44% -$1.2M ﹤0.01% 3347
2022
Q1 		$3.77M Buy
444,706
+22,786
+5% +$210K ﹤0.01% 2953
2021
Q4 		$5.05M Buy
421,920
+2,319
+0.6% +$35.4K ﹤0.01% 2897
2021
Q3 		$7.43M Buy
419,601
+4,928
+1% +$93K ﹤0.01% 2682
2021
Q2 		$8.51M Buy
414,673
+218,101
+111% +$4.3M ﹤0.01% 2575
2021
Q1 		$3.9M Buy
196,572
+27,972
+17% +$650K ﹤0.01% 2905
2020
Q4 		$3.13M Sell
168,600
-7,721
-4% -$169K ﹤0.01% 2845
2020
Q3 		$4.44M Buy
+176,321
New +$4.4M ﹤0.01% 2461
2020
Q2 		– Sell
-3,584
Closed -$111K – 4128
2020
Q1 		$111K Buy
+3,584
New +$148K ﹤0.01% 3731

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Geode Capital Management's RCEL Position: Q2 2026 in Review

Geode Capital Management reduced its Avita Medical (RCEL) stake by 37% in Q2 2026, selling an estimated $876K and leaving 339,822 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3271.

Geode Capital Management first reported a position in RCEL in Q1 2020 and has held it in 25 quarters since. The position peaked at $8.71M in Q1 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Geode Capital Management held 339,822 shares of Avita Medical worth $1.4M as of Q2 2026.
  • Geode Capital Management sold 203,152 Avita Medical shares in Q2 2026, an estimated $876K.
  • Avita Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3271 holding.
  • Geode Capital Management first reported a position in Avita Medical in Q1 2020 and has held it in 25 quarters since.
  • Geode Capital Management's Avita Medical position peaked at $8.71M in Q1 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.